RESOLUTE International : Registry for evaluation of Endeavor Resolute, a drug eluting stent in a Real-Worldpatient population.
- Conditions
- Health Condition 1: null- All consecutive patients eligible for drug-eluting stent implantation with the elective use of the Endeavor Resolute stent in one or more target lesions are candidates to be enrolled.
- Registration Number
- CTRI/2009/091/000416
- Lead Sponsor
- Medtronic Bakken Research Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 2200
1. Age more that or equal 18 years or minimum age as required by local regulations.
2. The patient is an acceptable candidate for treatment with a drug-eluting stent in accordance with the applicable guidleines on percutaneous coronary interventions, the Instructions for Use of the Endeavor Resolute stend and the Declaration of Helsinki.
3. The patient or legal representative has been informed of the nature of the trial and has consented to participate and authorized the collection and release of his medical information by signing a consent form (Patient Informed Consent Form or Patient Data Release Authorization Form).
4. Intention to electively implant at least one Endeavor Resolute stent.
1. Pregnancy.
2. High probability of non-adherence to the follow-up requirements (due to social,psychological or medical reasons).
3. Currently participating in another trial preventing routine hospital treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method